CACNA1C and Behcet disease: The first genome-wide association study (GWAS) that suggested CACNA1C to be a susceptibility gene for BD was performed on 1461 BD patients and 2008 control individuals, collected as part of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) and the University College London (UCL) sample.